SCHEMBL22609254

SCHEMBL22609254

O=C(O)c1nnccc1Nc1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ PTGS1 P23219 2/20 0.40
▸ PTGS2 P35354 2/20 0.40
▸ MAPK8 P45983 1/20 0.40
▸ CDC7 O00311 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ PAK4 O96013 1/20 0.40
▸ PIM1 P11309 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ FLT3 P36888 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ CDK9 P50750 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ MELK Q14680 1/20 0.40
▸ MINK1 Q8N4C8 1/20 0.40
▸ HIPK2 Q9H2X6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23486417 0.85 FABP4 (0.46) DHODHALDH1A1HTTPTGS1PTGS2
SCHEMBL29552554 0.81 HTR2C (0.40) ALDH1A1RAB9ACDK2GSK3BMEN1
SCHEMBL22609263 0.79 LMNA (0.50) ALDH1A1HTTRAB9AMEN1KMT2A
SCHEMBL22609297 0.78 P4HTM (0.48) ALDH1A1HTTRAB9AKMT2AP4HTM
SCHEMBL4908858 0.74 NPC1 (0.43) DHODHALDH1A1RAB9AMAPK8CDC7
SCHEMBL29008885 0.72 KDM4E (0.44) ALDH1A1HTTKMT2AMAPT
SCHEMBL29552239 0.70 L3MBTL1 (0.47) ALDH1A1PTGS2CDK9EGFR
SCHEMBL8834266 0.69 DHODH (0.53) DHODHALDH1A1PTGS1MAPK8CDC7
SCHEMBL1415570 0.69 MAPT (0.56) DHODHALDH1A1PTGS1CDC7DAPK3
SCHEMBL7455493 0.69 PDE10A (0.60) DHODHPTGS1PTGS2MAPK8CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed
EP-3731840-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF Orfan Biotech Inc. (US) 2020-11-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS DHODH 123/4885ALDH1A1 149/4885HTT 4735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback